Clinical trials: sponsored by Oslo University Hospital
Juvenile Idiopathic Arthritis (JIA)
Withdrawal Versus Continued TNF Inhibitor Monotherapy Treatment in Children With Inactive Juvenile Idiopathic Arthritis
The goal of this clinical trial is to learn whether children and adolescents with juvenile idiopathic arthritis (JIA) who have had inactive disease for a long time can safely discontinue treatment with a tumour necrosis factor…
- Trial name
- The Treat-JIA (NCT07904780)
- Testing
- Adalimumab, Etanercept, Golimumab
- Where
- 3 sites in Norway
- Volunteers
- 90 people
- Sponsor
- Oslo University Hospital
Thoracolumbar Burst Fracture
StUdy oN Burst Fractures (SunBurst)
Thoracolumbar (TL) burst fractures are seen in all ages and usually associated with high-energy trauma. Treatment include both surgical and non-surgical options.
- Trial name
- SunBurst (NCT05003180)
- Testing
- Surgical stabilization
- Where
- 17 sites in Norway, Sweden
- Volunteers
- 202 people
- Sponsor
- Uppsala University
Spinal Cord Injuries, Myelopathy
Efficacy of rTMS Treatment After Spinal Cord Injury
There is accumulating evidence that neuromodulation by repetitive transcranial magnetic stimulation (rTMS) of the motor cortex holds promise as a treatment for rehabilitation of motor function following a spinal cord injury.
- Trial name
- NCT06464744
- Testing
- Repetitive transcranial magnetic stimulation (rTMS)
- Where
- Norway
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- Oslo University Hospital
GTPS - Greater Trochanteric Pain Syndrome, Gluteal Tendinopathy
The HIP Self-management Study
The HIPS-study will be an observer blinded, single-centre, parallel-group randomized controlled trial (RCT). The main purpose of the study is: 1.
- Conditions
- GTPS - Greater Trochanteric Pain Syndrome, Gluteal Tendinopathy, Trochanteric Bursitis, Lateral Hip Pain
- Trial name
- HIPS (NCT06297148)
- Testing
- Self-management, Usual care
- Where
- Norway
- Volunteers
- 110 people
- Sponsor
- Oslo University Hospital
Neuroblastoma (NBL), Ewing Sarcoma
GD2IL18CART Combined With Bevacizumab for Relapsed and Refractory GD2-positive Solid Tumors
This study will test a CAR T-cell treatment combined with bevacizumab in children and young adults with relapsed or refractory neuroblastoma, Ewing sarcoma, or osteosarcoma.
- Conditions
- Neuroblastoma (NBL), Ewing Sarcoma, Osteosarcoma
- Trial name
- GD2CART-BEV (NCT07897968)
- Testing
- Chimeric Antigen Receptor (CAR) Therapy Infusion, Bevacizumab (Avastin)
- Where
- Germany
- Volunteers
- 30 people
- Sponsor
- Universität Münster
Substance Use Disorder (SUD)
Predicting Dropout and Outcome From Neuropsychological Functions in SUD Patients
The aim of this project is to gain a more specific understanding of how different cognitive profiles predict residential treatment drop-out, treatment retention and post-treatment outcome in a population with Substance Use…
- Trial name
- NCT03220373
- Where
- Norway
- Volunteers
- 200 people
- Sponsor
- Oslo University Hospital
Aortic Valve Stenosis, Myocardial Fibrosis
Quantification of Myocardial Fibrosis in Aortic Stenosis
This study is a long term follow-up of patients that were included as part of a previous study (NCT03422770), where patients with aortic stenosis and healthy controls went through echocardiography, cardiac MRI, long-term…
- Trial name
- SAS-F-5 (NCT06571175)
- Testing
- High frame rate echocardiography, MRI, Blood test
- Where
- Norway
- Volunteers
- 79 people
- Sponsor
- Norwegian University of Science and Technology
Liver Metastases, Colorectal Cancer
EXtended CriteriA Treatment for LIver Metastases and Heavy Tumour BURden
Patients with multiple colorectal liver metastases that progress on 1st line chemotherapy have a very dismal prognosis, and their options are few.
- Trial name
- EXCALIBUR3 (NCT04840186)
- Testing
- Liver-resection or ablation, 2nd line chemotherapy
- Where
- Norway
- Volunteers
- 62 people
- Sponsor
- Oslo University Hospital
Alcoholic Liver Disease (ALD), Alcohol Use Disorder
Elastography-based Brief Alcohol Intervention in Hospitalized Individuals
Harmful alcohol use is a common cause of hospital admissions and the leading cause of liver cirrhosis. Timely detection of liver disease is crucial to prevent liver disease progression and reduce alcohol-related harms.
- Trial name
- PREDILECTION (NCT07637539)
- Testing
- Elastography-based brief alcohol intervention
- Where
- 8 sites in Norway
- Volunteers
- 500 people
- Sponsor
- Oslo University Hospital
Colorectal Cancer, Liver Metastases
HAI-Floxuridine, or Liver-Tx, Combined With 2nd Line Chemotherapy Versus 2nd Line Chemotherapy Alone for Patients With Colorectal Liver Metastases and Heavy Tumour Burden.
Patients with colorectal livermetasteses and heavy tumour burden and progression on 1st line chemotherapy have no other available treatment in Norway today other than 2nd line chemotherapy.
- Conditions
- Colorectal Cancer, Liver Metastases, Chemotherapy Effect
- Trial name
- EXCALIBUR1+2 (NCT04898504)
- Testing
- Floxuridine, Liver Transplantation
- Where
- Norway
- Volunteers
- 39 people
- Sponsor
- Oslo University Hospital
Heart Transplantation
Donor Derived Cell Free DNA (Dd-cfDNA) as a Biomarker for Allograft Rejection in Heart Transplant Recipients
Following heart transplantation (HTx), lifelong immunosuppressive treatment is required to prevent the immune system from attacking, damaging, and rejecting the donor hear (allograft).
- Trial name
- TRANSCEND (NCT07886489)
- Testing
- Donor-derived cell free DNA
- Where
- 3 sites in Denmark, Norway
- Volunteers
- 100 people
- Sponsor
- University of Aarhus
Cancer, Palliative Care, Patient Care
Dexmedetomidine for Refractory Pain in Palliative Cancer Patients
The goal of this study is to find out whether the medication dexmedetomidine can be a safe and effective additional treatment for cancer patients whose pain is not well controlled by standard pain medicines (such as opioids).
- Conditions
- Cancer, Palliative Care, Patient Care, Pain Management, Dexmedetomidine Analgesia
- Trial name
- DEX-PAL (NCT07885475)
- Where
- 4 sites in Norway
- Volunteers
- 30 people
- Sponsor
- St. Olavs Hospital
Idiopathic Increased Femoral Anteversion
The FDR (Femoral Derotaton) Trail.
Femoral derotational osteotomy is the gold standard to correct symptomatic patients with increased femoral AV. There is no clear evidence in the literature supporting which surgical technique or implant that should be used.
- Trial name
- FDR (NCT04086368)
- Testing
- Adolescent Lateral Entry Femoral Nail, Pediatric LCP Hip Plate System
- Where
- Norway
- Volunteers
- 31 people, healthy volunteers welcome
- Sponsor
- Oslo University Hospital
Soft Tissue Sarcoma
Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma
Nearly half of patients with high-grade, localized soft tissue sarcoma (STS) of extremities and trunk wall develop disease recurrence after local therapy.
- Trial name
- NCT04776525
- Testing
- Ifosfamide, Doxorubicin
- Where
- 2 sites in Norway
- Volunteers
- 49 people
- Sponsor
- Oslo University Hospital
Olecranon Fracture
Treatment of Olecranon Fractures in the Elderly
Operative treatment, with tension band wiring or plate fixation, will be compared with non-operative treatment of displaced olecranon fractures (Mayo classification 2A and 2B) in patients 75 years or older.
- Trial name
- CROFT2 (NCT04670900)
- Testing
- Tension band wiring or plate fixation, Active non-operative treatment with optional plaster cast
- Where
- 12 sites in Norway, Sweden
- Volunteers
- 76 people
- Sponsor
- Oslo University Hospital
Anal Cancer
Anal Cancer Radiotherapy Study
This is a prospective study of patients receiving radiotherapy or chemoradiotherapy for anal cancer. Treatment effect in terms of survival and local recurrence will be analyzed.
- Trial name
- ANCARAD (NCT01937780)
- Where
- Norway
- Volunteers
- 75 people
- Sponsor
- Oslo University Hospital
Hepatitis B
Decentralization of Hepatitis B Care in Sub-Saharan Africa: a Pilot Program in Ethiopia
The goal of this observational study is to study models of care for decentralized hepatitis B treatment in Ethiopia. Three different models of decentralized HBV care (standard model, simplified model, test-and-treat model) will…
- Trial name
- NCT06586983
- Testing
- Tenofovir Disoproxil Fumarate
- Where
- Ethiopia
- Volunteers
- 4,500 people
- Sponsor
- Oslo University Hospital
Kidney Transplant; Complications, Kidney Transplant Failure
Can Dapagliflozin Preserve Structure and Function in Transplanted Kidneys?
The goal of this clinical trial is to look at the effect of SGLT2 (Sodium glucose transporter 2) inhibition in patients receiving a kidney-transplant 6 weeks earlier at Oslo University hospital. Rikshospitalet.
- Conditions
- Kidney Transplant; Complications, Kidney Transplant Failure, Renal Failure
- Trial name
- DEAKTransplant (NCT05788276)
- Testing
- Dapagliflozin 10mg Tab
- Where
- Norway
- Volunteers
- 330 people
- Sponsor
- Oslo University Hospital
Kidney Transplant Infection, SARS-CoV Infection
Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19)
None of the vaccines approved, or in clinical trials, have so far been tested on transplanted patients. If they produce an immune response to the Spike protein of SARS-CoV-2 it is unknown how long the protective immunity will…
- Trial name
- SCV-KTx-imm (NCT04747522)
- Testing
- SARS-CoV-2 vaccine
- Where
- Norway
- Volunteers
- 200 people
- Sponsor
- Oslo University Hospital
Myocardial Infarction
The Norwegian Trial of Physical Exercise After Myocardial Infarction
Myocardial infarction (MI) remains the main cause of death in Europe with about 2 million deaths annually. According to WHO, 30 % of deaths caused by MI could be prevented if the populations adhere to official guidelines for…
- Trial name
- NorEx (NCT04617639)
- Testing
- Physical exercise, Standard care, Observation group
- Where
- Norway
- Volunteers
- 9,513 people
- Sponsor
- Norwegian University of Science and Technology
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.